Hypertension in acromegaly and in the normal population: prevalence and determinants

被引:83
作者
Vitale, G [1 ]
Pivonello, R [1 ]
Auriemma, RS [1 ]
Guerra, E [1 ]
Milone, F [1 ]
Savastano, S [1 ]
Lombardi, G [1 ]
Colao, A [1 ]
机构
[1] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy
关键词
D O I
10.1111/j.1365-2265.2005.02370.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The GH/IGF-I axis has a relevant role to play in the cardiovascular system but its implication in the pathogenesis of hypertension in the normal population and in acromegaly is not yet clear. Patients and measurementsThe aim of this retrospective and controlled study was to evaluate the prevalence and determinants of hypertension in 200 patients with acromegaly and 200 nonacromegalic subjects, matched for sex, age, body mass index (BMI) and smoking habits. Results Hypertension was found in 46% of patients and in 25% of controls (P < 0.0001), without any difference between men and women. Family history of hypertension occurred in 30% of hypertensive acromegalic patients and in 62% of hypertensive controls (P < 0.0001). In both groups, hypertensive subjects were older than normotensive subjects. Systolic (SBP) and diastolic blood pressures (DBP) in hypertensive acromegalic patients were lower and higher, respectively, than in hypertensive controls. The risk of hypertension increased with age and was higher in the patients than in the controls [hazard ratio (HR) 1.9; P = 0.0002]. Independent predictors of SBP were age and glucose in the acromegalic population, and BMI, age and glucose levels in the controls. Independent predictors of DBP were age and glucose in the patients, and BMI, age and IGF-I in the controls. Conclusions In acromegaly, hypertension is more frequent than in the general population, involves predominantly DBP, and occurs earlier, is not related to gender, and is less frequently related to family history of hypertension and IGF-I levels. IGF-I may have a protective role for DBP in the general population.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 53 条
  • [1] Insulin-like growth factor 1 and pressure load in hypertensive patients
    Andronico, G
    Mangano, MT
    Ferrara, L
    Lamanna, D
    Mule, G
    Cerasola, G
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (06) : 607 - 609
  • [2] Regulation of vascular smooth muscle cell apoptosis - Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway
    Bai, HZ
    Pollman, MJ
    Inishi, Y
    Gibbons, GH
    [J]. CIRCULATION RESEARCH, 1999, 85 (03) : 229 - 237
  • [3] BATES AS, 1993, Q J MED, V86, P293
  • [4] BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327
  • [5] BIOSYNTHETIC GROWTH-HORMONE INCREASES THE COLLAGEN DEPOSITION RATE IN RAT AORTA AND HEART
    BRUEL, A
    OXLUND, H
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (02) : 195 - 199
  • [6] Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo
    Chen, Y
    Capron, L
    Magnusson, JO
    Wallby, LA
    Arnqvist, HJ
    [J]. GROWTH HORMONE & IGF RESEARCH, 1998, 8 (04) : 299 - 303
  • [8] Acromegaly
    Colao, A
    Merola, B
    Ferone, D
    Lombardi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) : 2777 - 2781
  • [9] Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy
    Colao, A
    Baldelli, R
    Marzullo, P
    Ferretti, E
    Ferone, D
    Gargiulo, P
    Petretta, M
    Tamburrano, G
    Lombardi, G
    Liuzzi, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) : 193 - 199
  • [10] Cardiovascular effects of depot long-acting somatostatin analog sandostatin LAR in acromegaly
    Colao, A
    Marzullo, P
    Ferone, D
    Spinelli, L
    Cuocolo, A
    Bonaduce, D
    Salvatore, M
    Boerlin, V
    Lancranjan, I
    Lombardi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) : 3132 - 3140